Topical Minoxidil for Pattern Hair Loss: Gupta 2015 Research Summary
This is a plain-language summary of the original published research. We do not add conclusions or opinions of our own. This is not medical advice — consult a certified healthcare practitioner before making any decision.
Original research published in Dermatologic Surgery, 2015
Topical Minoxidil for Pattern Hair Loss: Gupta 2015 Research Summary
Study conclusion
This study combined results from multiple controlled trials of topical minoxidil applied to the scalp for pattern hair loss. Minoxidil significantly increased hair count compared to placebo in both men and women. Both investigator assessments and patients themselves rated minoxidil as significantly more effective than placebo.
Strength of evidence
Who it applies to
Who was studied
Adults with pattern hair loss caused by genetics and hormones. Both men and women. Trials used topical minoxidil applied directly to the scalp, typically 2% or 5% solution or foam.
Who was NOT studied
People with alopecia areata, scarring alopecia, or hair loss from medication or illness. People using oral minoxidil (the tablet form).
What to look for when shopping
Both 2% and 5% minoxidil concentrations were studied. 5% was found to be more effective than 2% in men. Both concentrations showed significant improvement over placebo. Topical minoxidil is FDA-approved for pattern hair loss — the only topical treatment with this approval.
What research cannot help you decide
How long you need to use it to maintain results — trials did not follow people after stopping. Whether it works better combined with finasteride or other treatments for your specific situation. Which formulation (solution, foam) suits you best.
Key findings
- Topical minoxidil significantly increased total hair count compared to placebo (mean difference 16.68 hairs per square centimetre)
- Non-vellus (thicker, visible) hair count also increased significantly (mean difference 20.90 hairs per square centimetre)
- Both investigator and patient assessments rated minoxidil as significantly better than placebo
- 5% concentration showed stronger results than 2% concentration in men
- Topical minoxidil is FDA-approved for pattern hair loss in both men and women
What this study does not show
- 1.Whether results last after stopping. All trials measured results during active treatment. Hair loss typically returns after stopping minoxidil.
- 2.Whether combining minoxidil with other treatments improves results further. This review studied minoxidil alone against placebo.
- 3.What happens with very long-term use beyond the trial periods studied.
- 4.Whether oral minoxidil produces different results. This review covers topical application only.
Limitations
- 1.All trials studied minoxidil vs placebo, not against other active treatments.
- 2.Follow-up periods were limited — long-term maintenance data was not included.
- 3.Different trial designs and outcome measures were used across included studies.
- 4.The review was published in 2015. More recent trials may affect conclusions.
Used in these articles
Links added as fact-checks and articles citing this study are published.